{"title": "Transmission potential of COVID-19 in South Korea", "doi": "10.1101/2020.02.27.20028829", "citation_id": "2020.02.27.20028829v2", "date": "2020-03-02", "laguage": "en", "journal_title": "medRxiv", "first_page": "2020.02.27.20028829", "abstract": "<p>Since the first identified individual of 2019 novel coronavirus (COVID-19) infection on Jan 20, 2020 in South Korea, the number of confirmed cases rapidly increased. As of Feb 26, 2020, 1,261 cases of COVID-19 including 12 deaths were confirmed in South Korea. Using the incidence data of COVID-19, we estimate the reproduction number at 1.5 (95% CI: 1.4-1.6), which indicates sustained transmission and support the implementation of social distancing measures to rapidly control the outbreak.</p>", "twitter_description": "Since the first identified individual of 2019 novel coronavirus (COVID-19) infection on Jan 20, 2020 in South Korea, the number of confirmed cases rapidly increased. As of Feb 26, 2020, 1,261 cases of COVID-19 including 12 deaths were confirmed in South Korea. Using the incidence data of COVID-19, we estimate the reproduction number at 1.5 (95% CI: 1.4-1.6), which indicates sustained transmission and support the implementation of social distancing measures to rapidly control the outbreak.\n\n### Competing Interest Statement\n\nThe authors have declared no competing interest.\n\n### Funding Statement\n\nFor ES and WC, this work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2018R1C1B6001723).\n\n### Author Declarations\n\nAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.\n\nYes\n\nAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.\n\nYes\n\nI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).\n\nYes\n\nI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.\n\nYes\n\nWe obtained the daily series of confirmed cases of COVID-19 in South Korea from January 20, 2020 to February, 26, 2020 that are publicly available from the Korea Centers for Disease Control and Prevention (KCDC)\n\n<https://www.cdc.go.kr/board/board.es?mid=a30402000000&bid=0030>", "full_text_html_url": "https://www.medrxiv.org/content/10.1101/2020.02.27.20028829v2.full", "public_url": "https://www.medrxiv.org/content/10.1101/2020.02.27.20028829v2", "abstract_html_url": "https://www.medrxiv.org/content/10.1101/2020.02.27.20028829v2.abstract", "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/03/02/2020.02.27.20028829.full.pdf", "rights": "\u00a9 2020, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), CC BY-NC 4.0, as described at http://creativecommons.org/licenses/by-nc/4.0/", "publisher": "Cold Spring Harbor Laboratory Press", "pisa": "medrxiv;2020.02.27.20028829v2", "access_rights": "restricted", "authors": ["Eunha Shim", "Amna Tariq", "Wongyeong Choi", "Yiseul Lee", "Gerardo Chowell"]}